. 2006 Oct;14(10):343-344.

Intracoronary abciximab

S Ruiz Bustillo, P Stella, P A F M Doevendans

PMID: 25696562
PMCID: PMC2557316

Intracoronary abciximab

S Ruiz Bustillo et al. Neth Heart J. 2006 Oct.

. 2006 Oct;14(10):343-344.

Authors

S Ruiz Bustillo, P Stella, P A F M Doevendans

PMID: 25696562
PMCID: PMC2557316

Abstract

Here we report the potential benefits of the use of intracoronary abciximab during percutaneous coronary intervention for an acute myocardial infarction.

Keywords: PCI; abciximab (intracoronary); myocardial infarction (acute); thrombus.

PubMed Disclaimer

Similar articles

ClearWayRX system to reduce intracoronary thrombus in patients with acute coronary syndromes according to optical coherence tomography after abciximab intracoronary local infusion trial (COCTAIL): study rationale and design.
Capodanno D, Prati F, Pawlowsky T, Ramazzotti V, Albertucci J, La Manna A, Robert G, Tamburino C. Capodanno D, et al. J Cardiovasc Med (Hagerstown). 2010 Feb;11(2):130-6. doi: 10.2459/JCM.0b013e32832e0ae1. J Cardiovasc Med (Hagerstown). 2010. PMID: 19829141 Clinical Trial.
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G. Thiele H, et al. Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16. Circulation. 2008. PMID: 18559698 Clinical Trial.
Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ. Gu YL, et al. Circulation. 2010 Dec 21;122(25):2709-17. doi: 10.1161/CIRCULATIONAHA.110.002741. Epub 2010 Nov 15. Circulation. 2010. PMID: 21098442 Clinical Trial.
Rationale for intracoronary administration of abciximab.
Romagnoli E, Burzotta F, Trani C, Biondi-Zoccai GG, Giannico F, Crea F. Romagnoli E, et al. J Thromb Thrombolysis. 2007 Feb;23(1):57-63. doi: 10.1007/s11239-006-9000-0. J Thromb Thrombolysis. 2007. PMID: 17160551 Review.
A review of intracoronary abciximab in percutaneous coronary interventions--where are we now and where do we go from here?
Sharma S, Bhalla K, Singh S. Sharma S, et al. Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):192-6. doi: 10.2174/15748901113089990021. Recent Pat Cardiovasc Drug Discov. 2013. PMID: 23957238 Review.

See all similar articles

References

1. Catheter Cardiovasc Interv. 2004 Jan;61(1):31-4 - PubMed
1. Catheter Cardiovasc Interv. 2004 Jun;62(2):186-92 - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Intracoronary abciximab

Intracoronary abciximab

Authors

Abstract

Similar articles

References

LinkOut - more resources

Full Text Sources

Miscellaneous